About – MIM PHARMA

MIM Pharma has taken responsibility to act!

Our team of leading scientists, researchers, and medical experts has developed an antiviral and immune-enhancing solution that can help fight the COVID-19 and influenza virus and save lives. We have worked tirelessly to understand the underlying mechanisms of the COVID-19 virus and identify potential treatment targets. After years of research and development, we finally succeeded in creating a breakthrough multiple-indication antiviral herbal solution for COVID-19 outpatients which helps fight the virus, reduce the viral load, severity and duration of COVID-19 symptoms as well as hospitalization and mortality.

Published Innovation

Our anti-viral and immune-enhancing herbal solution research for COVID-19 has been published in Elsevier, the world’s largest publisher of medical and scientific literature.

As a result of the dedicated efforts of our team, the implementation of our innovative methodology and advanced technology we are pleased to announce our natural plant-based solution with multi-indications for antiviral and immune-enhancement properties, and the conclusion of clinical studies assessing the effectiveness of our COVID-19 medicinal solution. The results of these studies have been publicly disclosed, demonstrating outstanding outcomes. Furthermore, promising results from preclinical trials investigating the use of our therapeutic intervention against other viral agents, including influenza, have been observed.

Our unique approach to identifying the interaction between new viruses and medicinal plant compounds has proven to be of significant importance during global pandemics. The speed and efficiency with which our distinctive methodology operates facilitate timely identification and response to emerging viruses. This aspect of our approach is particularly valuable in light of the time-sensitive nature of epidemic and pandemic outbreaks.

Our next move is to make sure that it is accessible to those who needed it most. So we work closely with governments, healthcare providers, and other partners to ensure that our solution will be widely available and affordable, regardless of a person’s location or financial situation. Improving the life of patients is our ethical responsibility.

MIM Pharma continues to innovate and search for new and better ways to revolutionize the industry

with our excellent plant-based solutions and to help patients suffering from virus infection, migraines, rhinitis, and seasonal allergies.

Our Background

MIM Pharma’s research & development started in 2013. Our team is composed of experienced biopharma experts and business executives from the top universities of the world and long industry experience with a drive to transfer the legacy of deep-rooted natural medicine to modern pharmaceutical R&D and manufacturing techniques for introducing novel medical solutions for common diseases such as Covid-19, migraine, rhinitis, and seasonal allergy.

With our innovative and insightful technology, using the System Biology approach, MIM Pharma is applying advanced machine learning and natural language processing (NLP) techniques to help our researchers, engineers and clinicians perform their work even more effectively. Our highly skilled team of biochemists, engineers, and programmers work tirelessly to bring MIM Pharma to the forefront of the industry.

Our Vision

Transferring the legacy of deep-rooted-natural medicine to the modern pharmaceutical R&D and manufacturing techniques for introducing novel medical solutions We help humanity get rid of common and widespread ailments such as COVID-19, migraine, rhinitis, and seasonal allergy.

Our Mission

We will revolutionize the industry with our excellent plant-based solutions and help patients suffering from COVID-19, Migraines, Rhinitis, and seasonal allergies.

Our Values

We are a small science-driven, energetic, and entrepreneurial organization that contributes to the improvement of human health with our solutions.We emphasize innovation and continuous improvement both in our processes and medical solutions.We commit to the well-being of mankind, especially the patients. We act ethically and treat all with honesty and respect

Our Core Competency

We are a brilliant and distinguished research team with very rich backgrounds from high-ranked US, Germany, Iran, and Norway universities with very rich industrial experience.

Management team

We are so proud of what we do at MIM Pharma. Our team is composed of experienced biopharma experts and business executives from the top universities of the world and long industry experience with a drive to transfer the legacy of deep-rooted natural medicine to modern pharmaceutical R&D and manufacturing techniques for introducing novel medical solutions for common annoying diseases such as Covid-19, migraine, rhinitis, and seasonal allergy. The research and development team has achieved very promising results in treating these diseases. MIM Pharma management combines a wealth of talent and international experience in medicinal solution discovery and commercialization.

MIM Pharma has taken responsibility to act!

Published Innovation

MIM Pharma continues to innovate and search for new and better ways to revolutionize the industry

Our Background

Our Vision

Our Mission

Our Values

Our Core Competency

Peter Ressalehi

Dr. Reza Ramazani

Mona Hedvig Myhre

Saleh Ramazani

Jeanette Ressalehi

Management team

Peter Ressalehi

Dr. Reza Ramazani

Ferhat Atan

Mona Hedvig Myhre

Fateme Azadnia

Jeanette Ressalehi

Saleh Ramazani

Beate Christensen

MIM Pharma research contributors

Dr. Mohammad Reza Lornejad-Schäfer

Dr. Mohammad Shabani

Dr. Bahram Taheri